MedTrace Logo

Omega 3 Lipid Emulsions and Liver Transplantation

NCT01957943 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2017-03-28

No results posted yet for this study

Summary

The study Aims to investigate the possible beneficial impact of peri-operative or post-operative administration of Omega 3 enriched lipid emulsions on recipients for living donor liver transplantation.

Conditions

  • Ischemia Re-perfusion Injury

Interventions

DIETARY_SUPPLEMENT

SMOFLipid

DIETARY_SUPPLEMENT

equivalent volume of 10% glucose solution

Patients will receive same dose of 10% glucose solution for 2 days pre operatives and 5 days post-operative

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Amr M Yassen, MD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01957943 on ClinicalTrials.gov